ccc-R08

N/A

Report date: 2025/03/18 11:34:34
NME

Base Information

Drug Nameccc-R08
Drug Alias Nameccc-R08
ClassificationSmall molecules
Mechanisms of Actioncovalently closed circular DNA inhibitors
Targetscovalently closed circular DNA
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A